These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3597287)

  • 61. Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events?
    Bennabi M; Tarantino N; Gaman A; Scheid I; Krishnamoorthy R; Debré P; Bouleau A; Caralp M; Gueguen S; Le-Moal ML; Bouvard M; Amestoy A; Delorme R; Leboyer M; Tamouza R; Vieillard V
    Mol Autism; 2019; 10():22. PubMed ID: 31123562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The UCLA-University of Utah epidemiologic survey of autism: Recurrent infections.
    Mason-Brothers A; Ritvo ER; Freeman BJ; Jorde LB; Pingree CC; McMahon WM; Jenson WR; Petersen PB; Mo A
    Eur Child Adolesc Psychiatry; 1993 Apr; 2(2):79-90. PubMed ID: 29871451
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis.
    Sanctuary MR; Kain JN; Angkustsiri K; German JB
    Front Nutr; 2018; 5():40. PubMed ID: 29868601
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.
    Siniscalco D; Schultz S; Brigida AL; Antonucci N
    Pharmaceuticals (Basel); 2018 Jun; 11(2):. PubMed ID: 29867038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
    Gładysz D; Krzywdzińska A; Hozyasz KK
    Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
    Prata J; Santos SG; Almeida MI; Coelho R; Barbosa MA
    J Neuroinflammation; 2017 Sep; 14(1):179. PubMed ID: 28870209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.
    Griffiths KK; Levy RJ
    Oxid Med Cell Longev; 2017; 2017():4314025. PubMed ID: 28630658
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder.
    Onore C; Yang H; Van de Water J; Ashwood P
    Front Pediatr; 2017; 5():43. PubMed ID: 28361047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Killer Immunoglobulin - Like Receptor Gene - Content Haplotype and A Cognate Human Leukocyte Antigen Ligand are Associated with Autism.
    Torres A; Westover J; Benson M; Johnson R; Dykes A
    Autism Open Access; 2016 Apr; 6(2):. PubMed ID: 27853655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Role of the Immune System in Autism Spectrum Disorder.
    Meltzer A; Van de Water J
    Neuropsychopharmacology; 2017 Jan; 42(1):284-298. PubMed ID: 27534269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune mediators in the brain and peripheral tissues in autism spectrum disorder.
    Estes ML; McAllister AK
    Nat Rev Neurosci; 2015 Aug; 16(8):469-86. PubMed ID: 26189694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HLA Immune Function Genes in Autism.
    Torres AR; Westover JB; Rosenspire AJ
    Autism Res Treat; 2012; 2012():959073. PubMed ID: 22928105
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High complement factor I activity in the plasma of children with autism spectrum disorders.
    Momeni N; Brudin L; Behnia F; Nordström B; Yosefi-Oudarji A; Sivberg B; Joghataei MT; Persson BL
    Autism Res Treat; 2012; 2012():868576. PubMed ID: 22928102
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.
    Torres AR; Westover JB; Gibbons C; Johnson RC; Ward DC
    Brain Behav Immun; 2012 Oct; 26(7):1122-7. PubMed ID: 22884899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel blood-based biomarker for detection of autism spectrum disorders.
    Momeni N; Bergquist J; Brudin L; Behnia F; Sivberg B; Joghataei MT; Persson BL
    Transl Psychiatry; 2012 Mar; 2(3):e91. PubMed ID: 22832856
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder.
    Onore CE; Nordahl CW; Young GS; Van de Water JA; Rogers SJ; Ashwood P
    Biol Psychiatry; 2012 Dec; 72(12):1020-5. PubMed ID: 22717029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?
    Ewing GE
    N Am J Med Sci; 2009 Jul; 1(2):28-47. PubMed ID: 22666668
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of immune dysfunction in the pathophysiology of autism.
    Onore C; Careaga M; Ashwood P
    Brain Behav Immun; 2012 Mar; 26(3):383-92. PubMed ID: 21906670
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In search of cellular immunophenotypes in the blood of children with autism.
    Ashwood P; Corbett BA; Kantor A; Schulman H; Van de Water J; Amaral DG
    PLoS One; 2011 May; 6(5):e19299. PubMed ID: 21573236
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism.
    Wills S; Rossi CC; Bennett J; Martinez-Cerdeño V; Ashwood P; Amaral DG; Van de Water J
    Mol Autism; 2011 Apr; 2():5. PubMed ID: 21521495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.